Johns Hopkins Hospital
Johns Hopkins Hospital
United States of America, Maryland
Ovarian cancer treatment cost in the United States of America typically includes essential diagnostics like a PET-CT scan which ranges from Price on request to Price on request . Primary therapeutic interventions, such as ovarian cancer surgery, costs $50,000 to $120,000, while specialized options like HIPEC run from $35,000 to $55,000. Total expenditures depend on the disease stage, specific medication protocols, and regional clinic pricing. Top treatment destinations include New York and Maryland.
Typical Ovarian Cancer Treatment Costs in United States of America
Bookimed Expert Insight: Patients seeking the highest level of oncological expertise should prioritize NCI-designated centers. Memorial Sloan Kettering Cancer Center is the oldest and largest specialized oncology hospital globally. It offers access to researchers who develop innovative clinical programs for advanced cases. For those requiring a multidisciplinary approach, Johns Hopkins Hospital integrates medical school research with six specialized member centers. These institutions are best for complex or recurrent cancer requiring academic-level medical teams.
| United States of America | Turkey | Austria | |
| Оophorectomy | from $25,000 | from $2,500 | from $15,000 |
| Radiation therapy for colorectal cancer | from $25,000 | from $7,000 | from $12,000 |
| Ovarian cancer surgery | from $50,000 | from $4,800 | from $25,000 |
| Omentectomy | from $30,000 | from $4,500 | from $15,000 |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | from $35,000 | from $6,500 | from $40,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Ovarian cancer treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Ovarian cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Ovarian cancer treatment journey.
Standard ovarian cancer treatment in the U.S. combines cytoreductive surgery with platinum-based chemotherapy. Doctors follow National Comprehensive Cancer Network (NCCN) guidelines to personalize care. Protocols often include targeted maintenance therapies like PARP inhibitors or bevacizumab. Treatment focuses on removing visible tumors and preventing recurrence.
Bookimed Expert Insight: The choice between upfront surgery and neoadjuvant chemotherapy often hinges on tumor location. Memorial Sloan Kettering Cancer Center has the largest Da Vinci robot fleet in New York. This high-volume access allows surgeons to choose minimally invasive paths more frequently. These robotic techniques can lead to shorter hospital stays compared to traditional open debulking.
Patient Consensus: Patients emphasize requesting BRCA and HRD testing early to open maintenance therapy options. Many note that the decision for chemotherapy before surgery depends on how safely the surgeon can remove all visible disease.
Seeing a gynecologic oncologist for ovarian cancer significantly improves survival rates compared to general surgeons. These specialists manage complex debulking surgeries and administer advanced therapies like HIPEC. They are uniquely trained to identify and remove microscopic disease spread across the pelvic cavity and nearby organs.
Bookimed Expert Insight: Choosing a center with high patient volume is vital for surgical precision. Memorial Sloan Kettering Cancer Center treats over 200 cancer types and manages 120 research laboratories. This massive scale ensures surgeons encounter rare complications daily and maintain peak technical proficiency. Patients at such centers benefit from a multidisciplinary team that coordinates surgery, pathology, and chemotherapy.
Patient Consensus: Patients emphasize that a general surgeon might miss disease outside the primary mass. They strongly recommend starting with a specialist to avoid being referred mid-surgery when complexities arise.
Genetic and biomarker testing identifies specific molecular drivers of ovarian cancer cells. These tests enable precision medicine by matching patients to targeted therapies and immunotherapy. This transition from general care to individualized treatment plans ensures higher accuracy in addressing specific tumor mutations.
Bookimed Expert Insight: Genetic testing depth varies significantly by facility. Memorial Sloan Kettering Cancer Center has developed 9 Food and Drug Administration (FDA) approved drugs. This level of research allows centers to offer broader panels beyond basic BRCA testing. Patients benefit more from comprehensive analysis at centers with high oncology specialization.
Patient Consensus: Patients emphasize that testing results change family planning. Knowing about hereditary mutations helps siblings and children start preventative screenings earlier.
Clinical trials are research studies determining if new medical interventions are safe and effective. In the United States, patients access them through federal databases like ClinicalTrials.gov or specialized cancer centers. These trials follow strict Food and Drug Administration (FDA) protocols to protect participant safety.
Bookimed Expert Insight: Leading oncology centers like Memorial Sloan Kettering Cancer Center often provide access to drugs they developed themselves. Our data shows these facilities integrate research with clinical care, having developed 9 FDA-approved drugs. For ovarian cancer patients, seeking centers with extensive laboratory infrastructure increases the chance of finding mutation-driven trials early in treatment.
Patient Consensus: Patients emphasize that genetic testing for markers like BRCA or HER2 is essential for qualifying. Many note that identifying a trial early, rather than waiting for standard options to fail, is vital.
Fertility can be preserved if diagnosed with ovarian cancer at a young age. Success depends on the cancer type and treatment urgency. Options include egg or embryo freezing, ovarian tissue cryopreservation, and fertility-sparing surgery. These procedures must occur before chemotherapy or pelvic radiation starts.
Bookimed Expert Insight: US centers like Memorial Sloan Kettering Cancer Center utilize a large Da Vinci robot fleet for precise, minimally invasive surgeries. This technology helps surgeons perform fertility-sparing procedures more accurately than traditional open surgery. Preserving a single ovary also supports long-term bone and heart health through natural hormone balance.
Patient Consensus: Patients emphasize acting quickly because treatment schedules can sometimes prevent egg retrieval. Many find that keeping one ovary allowed for natural conception after less aggressive therapy ended.